Armata Pharmaceuticals Reports Shareholder Vote
Ticker: ARMP · Form: 8-K · Filed: Jun 14, 2024 · CIK: 921114
| Field | Detail |
|---|---|
| Company | Armata Pharmaceuticals, INC. (ARMP) |
| Form Type | 8-K |
| Filed Date | Jun 14, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
TL;DR
Armata Pharma held a shareholder vote on June 12th, details to follow.
AI Summary
Armata Pharmaceuticals, Inc. filed an 8-K on June 14, 2024, reporting on a matter submitted to a vote of its security holders on June 12, 2024. The filing does not disclose the specific outcome or details of the vote, only that it occurred.
Why It Matters
This filing indicates a significant event where shareholders voted on a matter, which could have implications for the company's future direction or governance.
Risk Assessment
Risk Level: medium — The filing is a procedural update about a shareholder vote, but the lack of detail on the vote's outcome or subject matter introduces uncertainty.
Key Players & Entities
- Armata Pharmaceuticals, Inc. (company) — Registrant
- June 12, 2024 (date) — Date of earliest event reported
- June 14, 2024 (date) — Filing date
- 001-37544 (company) — Commission File Number
FAQ
What specific matter was submitted for a vote by Armata Pharmaceuticals' security holders?
The filing does not specify the exact matter that was submitted for a vote by security holders on June 12, 2024.
What was the outcome of the shareholder vote on June 12, 2024?
The filing does not disclose the results or outcome of the shareholder vote that took place on June 12, 2024.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on June 14, 2024.
What is Armata Pharmaceuticals' principal executive office address?
Armata Pharmaceuticals' principal executive offices are located at 5005 McConnell Avenue, Los Angeles, California, 90066.
What is Armata Pharmaceuticals' IRS Employer Identification Number?
Armata Pharmaceuticals' IRS Employer Identification Number is 91-1549568.
Filing Stats: 544 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2024-06-14 16:09:33
Filing Documents
- tm2417278d1_8k.htm (8-K) — 29KB
- 0001104659-24-071752.txt ( ) — 196KB
- armp-20240612.xsd (EX-101.SCH) — 3KB
- armp-20240612_lab.xml (EX-101.LAB) — 33KB
- armp-20240612_pre.xml (EX-101.PRE) — 22KB
- tm2417278d1_8k_htm.xml (XML) — 3KB
07
Item 5.07. Submission of Matters to a Vote of Security Holders. At the Annual Meeting of Shareholders held on June 12, 2024 (the "Meeting"), the shareholders of the Company elected seven members to our board of directors, each for a one-year term expiring at the annual meeting of shareholders in 2025, as follows: Members Number of Shares Voted For Number of Shares Withheld Broker Non- Votes Deborah L. Birx, M.D. 30,016,901 199,470 1,351,031 Jules Haimovitz 30,028,176 188,195 1,351,031 Odysseas D. Kostas, M.D. 29,393,679 822,692 1,351,031 Robin C. Kramer 30,083,215 133,156 1,351,031 Joseph M. Patti, Ph. D. 30,061,888 154,483 1,351,031 Todd C. Peterson, Ph. D. 30,069,000 147,371 1,351,031 Sarah Schlesinger, M.D. 29,393,400 822,971 1,351,031 At the Meeting, our shareholders next approved, on a non-binding advisory basis, the compensation of the Company's named executive officers. The vote for such approval was 30,142,693 shares for, 55,393 shares against, 18,285 shares abstaining, and 1,351,031 shares of broker non-votes. Also at the Meeting, our shareholders ratified the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. The vote for such ratification was 31,543,360 shares for, 20,716 shares against, 3,326 shares abstaining, and 0 shares of broker non-votes.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 14, 2024 Armata Pharmaceuticals, Inc. By: /s/ Richard Rychlik Name: Richard Rychlik Title: Principal Financial Officer and Corporate Controller -2-